Juan Jose
Cerezo Manchado
![Foto de Juan Jose](/img/uploaded/14d6f59c2d08bf4ede55c6ce981fc03d.jpeg)
![Foto de Hospital Universitari Sant Joan de Reus](/img/noimage_org.png)
Hospital Universitari Sant Joan de Reus
Reus, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitari Sant Joan de Reus (3)
2023
-
Edoxaban Versus Low-Molecular-Weight Heparin in Hospitalized COVID-19 Patients With Atrial Fibrillation
Clinical and Applied Thrombosis/Hemostasis, Vol. 29
-
Impact of New Onset Atrial Fibrillation in Hospitalized Patients with COVID-19. Results of the “ACO-VID” Registry
Clinical and Applied Thrombosis/Hemostasis, Vol. 29
-
Impact of atrial fibrillation and anticoagulation on the risk of death, thromboembolic disease and bleeding in patients with COVID-19: the ACO-VID Registry
Current Medical Research and Opinion, Vol. 39, Núm. 6, pp. 811-817